Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Compounding pharmacies Licensed pharmacies that prepare custom formulations
177Lu-PSMA-617 gained FDA approval in 2023 for patients with PSMA-positive mCRPC after progression on ARi and taxane-based chemotherapy, following the phase III VISION trial demonstrating that the combination of 177Lu-PSMA-617 with best standard-of-care (BSoC) therapy improved median overall survival and radiographic progression-free survival compared to BSoC alone (NCT03511664) 83
"Effect of Vitamin Supplements on HIV Shedding in Breast Milk." An J Clin Nutr 92.4 (2010): 881-6
$75.00 Original price was: $75.00.$59.99Current price is: $59.99
Ann Intern Med 167:268274
US$ 22.72
US$ 21.52
US$ 26.50
US$ 28.68
US$ 23.82
